Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Background and review question Migraine is a painful and debilitating disorder that is common in children (under 12 years of age) and adolescents (12 to 17 years of age). Common symptoms reported ...

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. The US Headache Consortium completed a landmark evidenced-based review of the literature concerning the diagnosis and treatment of migraine. [116] The ...

The Pathophysiological and Pharmacological Basis of Current Drug Treatment of Migraine Headache Doodipala Samba Reddy Disclosures Expert Rev Clin Pharmacol. 2013;6 (3):271-288. ... Migraine Genetics ...

β-Adrenoceptor Blockers For continuous prophylaxis, β-blockers are commonly used. [89, 93–96] Propranolol and timolol are FDA approved for migraine prophylaxis. Propranolol (Inderal®, Akrimax ...

Triptans: Selective Serotonin 5-HT 1 -Receptor Agonists 5-HT is a key mediator in the pathogenesis of migraine. 5-HT 1 -receptor agonists, commonly known as the 'triptans', are the mainstay for acute ...

Researchers at the Headache Centre of the University of Naples “Federico II” gave the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide to 26 adults with obesity and chronic migraine.

Migraine sufferers find relief with new treatment options by: Jakob Butler, Gretchen Bolander Posted: Jun 19, 2025 / 04:56 PM CDT Updated: Jun 20, 2025 / 09:30 AM CDT ...